Drugs / Fleet Enema
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT00696618 | Jul 2007 → Jul 2009 | HIV infectious disease | Johns Hopkins University | Completed | No outcome recorded |
| Phase not stated1 trial · 1 missed | ||||||
| — | NCT01917396 | Aug → Dec 2013 | — | Istanbul Bakirkoy Maternity and Children Diseases Hospital | Approved for marketing | Missed primary |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01715272 Comparator | Oct → Dec 2012 | — | Norgine | Completed | No outcome recorded |
| Phase 4 | NCT05148494 Comparator | Mar 2022 → Aug 2026 overdue | colorectal neoplasm | Nova Scotia Health Authority | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fleet enema | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01715272 ↗ |
| Known as | Fleet | “Patient is to administer one sodium bisphosphate (Fleet) enema at home 2 hours prior to arrival for surgery and a second enema one hour prior to arrival for surgery.” NCT05148494 ↗ |
| Route | Rectal | “The study group (n=65) was given a Fleet enema” PMID 22516178 ↗ Apr 2012 |